Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chebi:28462
2. Ncgc00016987-01
3. Ajimalin (tn)
4. Ajmaline (jp17)
5. Dsstox_cid_25537
6. Dsstox_rid_80939
7. Dsstox_gsid_45537
8. Schembl18950
9. Ajmalan-17alpha,21alpha-diol
10. Chembl2357792
11. Hy-b1167
12. Tox21_110728
13. 4-formylphenyl4-formylbenzoate
14. Akos037515833
15. Cs-4769
16. Db01426
17. Cas-4360-12-7
18. D00199
19. Q385858
20. (1r,9r,10s,12r,13s,14r,16s,18r)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.0^{1,9}.0^{2,7}.0^{10,15}.0^{12,17}]nonadeca-2,4,6-triene-14,18-diol
Molecular Weight | 326.4 g/mol |
---|---|
Molecular Formula | C20H26N2O2 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 326.199428076 g/mol |
Monoisotopic Mass | 326.199428076 g/mol |
Topological Polar Surface Area | 46.9 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 570 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For use as an antiarrhythmic agent.
Ajmaline is a class 1A antiarrhythmic agent. By interfering with the sodium channels, this drug allows for improvement in abnormal rhythms of the heart
The class I antiarrhythmic agents interfere with the sodium channel. A class IA agent lengthens the action potential (right shift) which brings about improvement in abnormal heart rhythms. This drug in particular has a high affinity for the Nav 1.5 sodium channel.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?